BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21529932)

  • 1. The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.
    Canovi M; Markoutsa E; Lazar AN; Pampalakis G; Clemente C; Re F; Sesana S; Masserini M; Salmona M; Duyckaerts C; Flores O; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Aug; 32(23):5489-97. PubMed ID: 21529932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells.
    Markoutsa E; Papadia K; Clemente C; Flores O; Antimisiaris SG
    Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide.
    Mourtas S; Canovi M; Zona C; Aurilia D; Niarakis A; La Ferla B; Salmona M; Nicotra F; Gobbi M; Antimisiaris SG
    Biomaterials; 2011 Feb; 32(6):1635-45. PubMed ID: 21131044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.
    Gobbi M; Re F; Canovi M; Beeg M; Gregori M; Sesana S; Sonnino S; Brogioli D; Musicanti C; Gasco P; Salmona M; Masserini ME
    Biomaterials; 2010 Sep; 31(25):6519-29. PubMed ID: 20553982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta.
    Wang J; Hara H; Makifuchi T; Tabira T
    J Alzheimers Dis; 2008 Jun; 14(2):161-73. PubMed ID: 18560128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.
    Mourtas S; Lazar AN; Markoutsa E; Duyckaerts C; Antimisiaris SG
    Eur J Med Chem; 2014 Jun; 80():175-83. PubMed ID: 24780594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoliposomes presenting on surface a cis-glycofused benzopyran compound display binding affinity and aggregation inhibition ability towards Amyloid β1-42 peptide.
    Airoldi C; Mourtas S; Cardona F; Zona C; Sironi E; D'Orazio G; Markoutsa E; Nicotra F; Antimisiaris SG; La Ferla B
    Eur J Med Chem; 2014 Oct; 85():43-50. PubMed ID: 25072875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity.
    Markoutsa E; Mourtas S; Bereczki E; Zona C; La Ferla B; Nicotra F; Flores O; Pei JJ; Antimisiaris SG
    Curr Top Med Chem; 2015; 15(22):2267-76. PubMed ID: 26043735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease.
    Lazar AN; Mourtas S; Youssef I; Parizot C; Dauphin A; Delatour B; Antimisiaris SG; Duyckaerts C
    Nanomedicine; 2013 Jul; 9(5):712-21. PubMed ID: 23220328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
    Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
    Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against large oval aggregates of Aβ1-42.
    Shimizu T; Yoshimune K; Komoriya T; Akiyama T; Ye X; Kohno H
    J Biosci Bioeng; 2013 Feb; 115(2):216-20. PubMed ID: 23041139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the β-amyloid(4-10) epitope of plaque specific Aβ antibodies by affinity-mass spectrometry using alanine site mutation.
    Ștefănescu R; Lupu L; Manea M; Iacob RE; Przybylski M
    J Pept Sci; 2018 Jan; 24(1):. PubMed ID: 29322650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
    Levites Y; Das P; Price RW; Rochette MJ; Kostura LA; McGowan EM; Murphy MP; Golde TE
    J Clin Invest; 2006 Jan; 116(1):193-201. PubMed ID: 16341263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging amyloid plaque in Alzheimer's disease brain with a biotinylated Aβ peptide radiopharmaceutical conjugated to an IgG-avidin fusion protein.
    Sumbria RK; Boado RJ; Pardridge WM
    Bioconjug Chem; 2012 Jun; 23(6):1318-21. PubMed ID: 22624578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.
    Kanekiyo T; Ban T; Aritake K; Huang ZL; Qu WM; Okazaki I; Mohri I; Murayama S; Ozono K; Taniike M; Goto Y; Urade Y
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6412-7. PubMed ID: 17404210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.